Quality of survival in histiocytosis X: a Southwest Oncology Group study

Med Pediatr Oncol. 1980;8(1):35-40. doi: 10.1002/mpo.2950080106.

Abstract

Sixty children survived for five years after the diagnosis of histiocytosis X. Serious disabilities were seen in 50% of children whose disease involved soft tissue and bone. Late deaths from pulmonary failure were associated with opportunistic infections in two cases. Future treatment approaches must weigh the risks of therapy-related complications against the probability of significant disability if the disease continues for many years.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Follow-Up Studies
  • Histiocytosis, Langerhans-Cell / drug therapy
  • Histiocytosis, Langerhans-Cell / mortality
  • Histiocytosis, Langerhans-Cell / rehabilitation*
  • Humans
  • Infant
  • Prognosis
  • Quality of Life*
  • United States